Results & Financial lifeHealthcare - Pharma - Biotech
Monthly information on share capital and company voting rights
04/11/2026 22:30
AMFImmediate publication
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact:
Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority)
Listing market: Euronext Growth
ISIN code: FR0010425595
Date Total number of shares in the capital
Total number of voting rights
10/31/2026 100,732,781 105,562,774
For further information on Cellectis, please contact:
Media contacts:
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com
Publication réglementée diffusée via info-financière (AMF). Type : Informations réglementées continues Sous-type : Total du nombre de droits de vote et du capital ISIN : FR0010425595 Diffuseur : MKW
Le document officiel est disponible en lien.